Neuropathic Pain in Patients With Degenerative Lumbar Stenosis

Observational Cohort Study of the Neuropathic Pain in Surgical Treatment of Patients With Degenerative Lumbar Stenosis

Pre- and postoperative pain in patients with degenerative stenosis requires great attention, as it can mislead the doctor about treatment tactics. Neuropathic pain in the legs before and after the surgical procedure, as well as the residual or recurrent pain syndrome existing against this background, overshadow the patient's recovery and cast doubt on the fullness of the performed decompression. Neural compression in the spinal canal and back pain may be the cause of the patient's antalgic posture and sagittal imbalance as seen on X-Ray, to need for corrective interventions surgical procedure.

Thus, it is necessary to clarify the role and the influence of the pain and its type on the perioperative period in patients with degenerative lumbar spinal stenosis.

Study Overview

Detailed Description

The current study is prospective observational study to evaluate the role of pain syndrome including neuropathic pain in surgical outcomes in patients with degenerative lumbar spinal stenosis.

This study will be conducted at Priorov Central Institute for Trauma and Orthopedics, Moscow, Russia.

The study is expected to enroll at least 120 adult patients with degenerative lumbar stenosis. The neuropathy will be assessed preoperatively, and then the patient will undergo decompressive lumbar surgery without fusion.

The neuropathic pain will be evaluated according to DN4 preoperatively, each patient will be assigned to one of two groups depending on the total value of DN4 - with the presence of neuropathy (DN4>= 4) and without neuropathy (DN4 <4).

Postoperative evaluation will include 2 visits during one year to evaluate clinical and radiological outcomes.

Study Type

Observational

Enrollment (Estimated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Moscow, Russian Federation, 127299
        • Priorov National Medical Research Center of Traumatology and Orthopedics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

One study center in Russia will include adult patients with radicular leg pain with/without neurogenic claudication with/without back pain caused by degenerative spinal stenosis with MRI-confirmed nerve compression; with symptoms persisting for more than 3 months before surgery.

Description

Inclusion Criteria:

  1. Age 18-85 years;
  2. Radicular leg pain with or without neurogenic claudication with or without back pain;
  3. Planned decompressive surgery for degenerative lumbar stenosis with or without degenerative spondylolisthesis;
  4. Symptoms persisting for at least 3 months prior to surgery;
  5. Given written Informed Consent;
  6. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements

Exclusion Criteria:

  1. Prior lumbar fusion at any level;
  2. Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol;
  3. Back or non-radicular pain of unknown etiology;
  4. History or presence of any other major neurological disease or condition that may interfere with the study assessments (e.g. significant peripheral neuropathy, multiply sclerosis);
  5. Any other condition or situation that the investigator believes may interfere with the safety of the subject or the intent and conduct of the study;
  6. Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Neuropathic Pain
All patients will undergo lumbar decompression at stenosis levels (clinically and MRI confirmed) regardless of study group
DN4 includes a series of ten questions consisting of both sensory descriptors and signs related to bedside sensory examination
Other Names:
  • neuropathic pain diagnostic questionnaire
No Neuropathic Pain
All patients will undergo lumbar decompression at stenosis levels (clinically and MRI confirmed) regardless of study group
DN4 includes a series of ten questions consisting of both sensory descriptors and signs related to bedside sensory examination
Other Names:
  • neuropathic pain diagnostic questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Oswestry Disability Index (ODI)
Time Frame: 3 months postoperatively
To observe the change of Oswestry Disability Index as compared to baseline through follow-up terms
3 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Neuropathic Pain 4 Questions (DN4)
Time Frame: 2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
To observe the change of Neuropathic Pain 4 Questions as compared to baseline through follow-up terms
2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
Change from baseline in Numeric Pain Rating Scale (NPRS)
Time Frame: 2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
To observe the change of Numeric Pain Rating Scale as compared to baseline through follow-up terms
2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
Change from baseline in Oswestry Disability Index (ODI)
Time Frame: 12 months postoperatively
To observe the change of Oswestry Disability Index as compared to baseline through follow-up terms
12 months postoperatively
Change from baseline in The Health Transition Item from SF-36 (HTI Item)
Time Frame: 2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
To observe the change of The Health Transition Item as compared to baseline through follow-up terms
2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
Change from baseline in sagittal balance parameters
Time Frame: 3 months, 12 months postoperatively
To observe the change of sagittal balance parameters (index Barrey) as compared to baseline through follow-up terms
3 months, 12 months postoperatively
Change from baseline in regional balance parameters
Time Frame: 3 months, 12 months postoperatively
To observe the change of regional balance parameters (Segmental Lordosis) as compared to baseline through follow-up terms
3 months, 12 months postoperatively
Change from baseline in frontal balance parameters
Time Frame: 3 months, 12 months postoperatively
To observe the change of frontal balance parameters (Cobb's angle) as compared to baseline through follow-up terms
3 months, 12 months postoperatively
the safety parameters
Time Frame: during study, an average of 1 year
To observe and document the safety parameters (Adverse events)
during study, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 13, 2024

Primary Completion (Actual)

May 16, 2025

Study Completion (Estimated)

May 13, 2026

Study Registration Dates

First Submitted

April 24, 2024

First Submitted That Met QC Criteria

May 6, 2024

First Posted (Actual)

May 9, 2024

Study Record Updates

Last Update Posted (Actual)

August 20, 2025

Last Update Submitted That Met QC Criteria

August 14, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuropathic Pain

Clinical Trials on DN4 (Douleur Neuropathique 4 Questions) questionnaire

Subscribe